GGrantIndex
← Leaderboards

James R. Heath

California Institute Of Technology

$23,260,811
Attributed
$26,454,699
Total exposure
23
Grants
23
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.3M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$78,435,639 · 27

By mechanism

U54$69,342,950 · 24
R01$5,171,576 · 2
U01$3,921,113 · 1

Top collaborators

Most similar at California Institute Of Technology

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignMalignant NeoplasmsProgramsCancer CenterCellsResourcesNanosystemsResearch PersonnelTumorImmunotherapyTissuesBiologyTechnologyCancer BiologyBaseCommunitiesFundingIn VivoProteinsNanotechnologyMelanomaResistanceKineticsMolecular

Grant awards (117)

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$2,564,339
U54 · FY2025 · CA · contact PI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations$782,862
U54 · FY2025 · CA · contact PI
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization$523,564
R01 · FY2025 · CA · contact PI
Administrative Core$373,125
U54 · FY2025 · CA · contact PI
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$144,537
U54 · FY2025 · CA · contact PI
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$2,342,452
U54 · FY2024 · CA · contact PI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations$772,064
U54 · FY2024 · CA · contact PI
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization$509,788
R01 · FY2024 · CA · contact PI
Administrative Core$377,458
U54 · FY2024 · CA · contact PI
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$133,520
U54 · FY2024 · CA · contact PI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations$133,520
U54 · FY2024 · CA · contact PI
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$12,350
U54 · FY2024 · CA · contact PI
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$2,548,990
U54 · FY2023 · CA · contact PI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations$752,351
U54 · FY2023 · CA · contact PI
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization$528,041
R01 · FY2023 · CA · contact PI
Administrative Core$378,467
U54 · FY2023 · CA · contact PI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations$147,236
U54 · FY2023 · CA · contact PI
Data-driven Patient-Specific Agent Based Models of Metastatic Melanoma for Immunotherapy Response Prediction$147,236
U54 · FY2023 · CA · contact PI
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)$2,702,613
U54 · FY2022 · CA · contact PI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations$825,019
U54 · FY2022 · CA · contact PI
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization$547,911
R01 · FY2022 · CA · contact PI
Administrative Core$246,571
U54 · FY2022 · CA · contact PI
Steady states and cellular transitions associated with carcinogenesis and tumorprogression$670,711
U01 · FY2021 · CA · contact PI
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization$595,609
R01 · FY2021 · CA · contact PI
Steady states and cellular transitions associated with carcinogenesis and tumorprogression$670,576
U01 · FY2020 · CA · contact PI
Astrocyte and microglial cell state transitions in response to activation of the immune system in Alzheimer's disease$472,750
U01 · FY2020 · CA · contact PI
Repurposing of cancer therapeutics for treatment of patients with COVID-19 disease$183,000
U54 · FY2020 · CA · contact PI
Nanosystems Biology Cancer Center$1,997,668
U54 · FY2019 · CA · contact PI
Steady states and cellular transitions associated with carcinogenesis and tumorprogression$650,589
U01 · FY2019 · CA · contact PI
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies$632,739
U54 · FY2019 · CA · contact PI
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations$561,586
U54 · FY2019 · CA · contact PI
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K$223,654
U54 · FY2019 · CA · contact PI
NanoSystems Biology Cancer Center Nano/micro Fabrication and Materials (NM2) Core$158,291
U54 · FY2019 · CA · contact PI
Crump Preclinical Imaging Core$113,515
U54 · FY2019 · CA · contact PI
Administrative Core$107,747
U54 · FY2019 · CA · contact PI
Developmental Program: Nanosystems Biology Cancer Center$87,349
U54 · FY2019 · CA · contact PI
Nanosystems Biology Cancer Center$2,073,361
U54 · FY2018 · CA · contact PI
Steady states and cellular transitions associated with carcinogenesis and tumorprogression$812,211
U01 · FY2018 · CA · contact PI
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies$663,909
U54 · FY2018 · CA · contact PI
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations$585,360
U54 · FY2018 · CA · contact PI
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K$199,554
U54 · FY2018 · CA · contact PI
NanoSystems Biology Cancer Center Nano/micro Fabrication and Materials (NM2) Core$182,514
U54 · FY2018 · CA · contact PI
Crump Preclinical Imaging Core$120,393
U54 · FY2018 · CA · contact PI
Administrative Core$109,169
U54 · FY2018 · CA · contact PI
Developmental Program: Nanosystems Biology Cancer Center$85,681
U54 · FY2018 · CA · contact PI
Nanosystems Biology Cancer Center$1,393,912
U54 · FY2017 · CA · contact PI
Nanosystems Biology Cancer Center$1,009,425
U54 · FY2017 · CA · contact PI
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies$562,890
U54 · FY2017 · CA · contact PI
Steady states and cellular transitions associated with carcinogenesis and tumorprogression$543,527
U01 · FY2017 · CA · contact PI
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations$304,986
U54 · FY2017 · CA · contact PI
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies$277,899
U54 · FY2017 · CA · contact PI
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations$243,792
U54 · FY2017 · CA · contact PI
NanoSystems Biology Cancer Center Nano/micro Fabrication and Materials (NM2) Core$179,642
U54 · FY2017 · CA · contact PI
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K$163,341
U54 · FY2017 · CA · contact PI
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K$160,966
U54 · FY2017 · CA · contact PI
Steady states and cellular transitions associated with carcinogenesis and tumor progression$100,749
U01 · FY2017 · CA · contact PI
Crump Preclinical Imaging Core$74,564
U54 · FY2017 · CA · contact PI
NanoSystems Biology Cancer Center Nano/micro Fabrication and Materials (NM2) Core$63,727
U54 · FY2017 · CA · contact PI
Crump Preclinical Imaging Core$60,736
U54 · FY2017 · CA · contact PI
Administrative Core$51,326
U54 · FY2017 · CA · contact PI
Developmental Program: Nanosystems Biology Cancer Center$43,097
U54 · FY2017 · CA · contact PI
Administrative Core$41,001
U54 · FY2017 · CA · contact PI
Developmental Program: Nanosystems Biology Cancer Center$26,928
U54 · FY2017 · CA · contact PI
Nanosystems Biology Cancer Center$2,446,594
U54 · FY2016 · CA · contact PI
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies$642,335
U54 · FY2016 · CA · contact PI
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations$564,460
U54 · FY2016 · CA · contact PI
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K$377,219
U54 · FY2016 · CA · contact PI
NanoSystems Biology Cancer Center Nano/micro Fabrication and Materials (NM2) Core$147,358
U54 · FY2016 · CA · contact PI
Crump Preclinical Imaging Core$141,009
U54 · FY2016 · CA · contact PI
Administrative Core$118,839
U54 · FY2016 · CA · contact PI
Developmental Program: Nanosystems Biology Cancer Center$99,438
U54 · FY2016 · CA · contact PI
Nanosystems Biology Cancer Center$2,324,988
U54 · FY2015 · CA · contact PI
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies$637,991
U54 · FY2015 · CA · contact PI
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)$626,768
R01 · FY2015 · CA · contact PI
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations$565,542
U54 · FY2015 · CA · contact PI
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K$373,043
U54 · FY2015 · CA · contact PI
NanoSystems Biology Cancer Center Nano/micro Fabrication and Materials (NM2) Core$147,740
U54 · FY2015 · CA · contact PI
Crump Preclinical Imaging Core$142,057
U54 · FY2015 · CA · contact PI
Administrative Core$118,381
U54 · FY2015 · CA · contact PI
Developmental Program: Nanosystems Biology Cancer Center$99,439
U54 · FY2015 · CA · contact PI
Nanosystems Biology Cancer Center 2$2,357,460
U54 · FY2014 · CA · contact PI
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)$607,965
R01 · FY2014 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$137,183
U54 · FY2014 · CA · contact PI
Administrative Core$107,769
U54 · FY2014 · CA · contact PI
Education/Training and Outreach Activities$55,200
U54 · FY2014 · CA · contact PI
NanoFabrication and NanoMaterials Characterization Core$44,599
U54 · FY2014 · CA · contact PI
Nanosystems Biology Cancer Center 2$2,287,859
U54 · FY2013 · CA · contact PI
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)$589,162
R01 · FY2013 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$132,233
U54 · FY2013 · CA · contact PI
Administrative Core$104,293
U54 · FY2013 · CA · contact PI
Education/Training and Outreach Activities$53,208
U54 · FY2013 · CA · contact PI
NanoFabrication and NanoMaterials Characterization Core$42,991
U54 · FY2013 · CA · contact PI
Nanosystems Biology Cancer Center 2$2,463,138
U54 · FY2012 · CA · contact PI
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)$642,768
R01 · FY2012 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$141,426
U54 · FY2012 · CA · contact PI
Administrative Core$111,996
U54 · FY2012 · CA · contact PI
Education/Training and Outreach Activities$56,905
U54 · FY2012 · CA · contact PI
NanoFabrication and NanoMaterials Characterization Core$45,980
U54 · FY2012 · CA · contact PI
Nanosystems Biology Cancer Center 2$2,446,327
U54 · FY2011 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$140,177
U54 · FY2011 · CA · contact PI
Administrative Core$111,474
U54 · FY2011 · CA · contact PI
Education/Training and Outreach Activities$56,405
U54 · FY2011 · CA · contact PI
NanoFabrication and NanoMaterials Characterization Core$45,573
U54 · FY2011 · CA · contact PI
Nanosystems Biology Cancer Center 2$2,586,441
U54 · FY2010 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$145,800
U54 · FY2010 · CA · contact PI
Administrative Core$116,136
U54 · FY2010 · CA · contact PI
Education/Training and Outreach Activities$58,668
U54 · FY2010 · CA · contact PI
NanoFabrication and NanoMaterials Characterization Core$47,403
U54 · FY2010 · CA · contact PI
NanoSystems Biology Cancer Center$3,644,422
U54 · FY2009 · CA · contact PI
AMINISTRATION$270,355
U54 · FY2009 · CA · contact PI
EDUCATION AND TRAINING$38,042
U54 · FY2009 · CA · contact PI
NanoSystems Biology Cancer Center$3,546,396
U54 · FY2008 · CA · contact PI
AMINISTRATION$217,719
U54 · FY2008 · CA · contact PI
EDUCATION AND TRAINING$30,595
U54 · FY2008 · CA · contact PI
NanoSystems Biology Cancer Center$3,507,584
U54 · FY2007 · CA · contact PI
NanoSystems Biology Cancer Center$3,517,138
U54 · FY2006 · CA · contact PI
NanoSystems Biology Cancer Center$3,599,190
U54 · FY2005 · CA